Organoids, organs-on-a-chip, and machine learning technologies have improved dramatically in recent years, but have they come ...

No longer will our medicines be gated through animals, but rather through entirely human systems — leading to breakthrough ...

On April 10, the Food and Drug Administration announced plans to phase out animal testing requirements for the development of ...

The FDA and NIH recently announced plans to phase out animal testing requirements for some therapies. While organoid and AI ...

The initiatives reflect the latest measures from federal agencies to reduce and ultimately replace animal testing in drug development and ...

The FDA has said it intends to reduce or replace animal testing of some medicines, including monoclonal antibodies, with other methods that it hopes will be more relevant to human physiology.

Animal welfare groups had long accused the National Institutes of Health of killing thousands of beagles in septic shock ...

The U.S. Food and Drug Administration (FDA) recently announced it plans to phase out animal testing in the development of monoclonal antibody therapies and other drugs and biological products ...

The world’s largest funder of biomedical and public health research in will now prioritize innovative health research, leaving outdated animal experiments behind.

The FDA says that over the next 3–5 years it aims “to make animal studies the exception rather than the norm” for preclinical safety testing, starting with monoclonal antibodies and ...

This comes as the U.S. Federal Drug Administration works to move away from animal testing for pharmaceuticals altogether. The FDA made a historic decision to phase out animal testing and switch to ...

The way we test new medicines in the U.S. is about to change. The FDA is officially moving away from animal testing and embracing new technologies that rely on human cells and artificial intelligence.